Navigation Links
Boulder Diagnostics Licenses Novel Rapid Detection Technology for Homocysteine and Related Compounds from Portland State University
Date:1/20/2012

BOULDER, Colo. and PORTLAND, Ore., Jan. 20, 2012 /PRNewswire/ -- Boulder Diagnostics Inc. and Portland State University (PSU) announced today the entry into a license and collaboration agreement to develop rapid diagnostic tests for homocysteine and related compounds based on a highly specific dye technology developed at PSU. Under the agreement Boulder will finance further research at the Department of Chemistry, and PSU will be entitled to royalties on future sales of the licensed technology. Further details were not disclosed.

The innovative and highly specific dye technology developed in the laboratory of Prof. Robert Strongin at PSU enables the development of rapid diagnostic tests for homocysteine and related compounds. The new dye technology will be used in medical tests to help determine indicators for a variety of diseases, including cancer, Alzheimer's, Parkinson's, cystic fibrosis, and HIV.

"The groundbreaking technology of Prof. Strongin and his team can form the basis for a new line of products," says Wolfgang Pieken, CEO of Boulder Diagnostics Inc.

"We are excited to adapt our innovative detection chemistry to rapid diagnostic tests with Boulder Diagnostics," comments Robert Strongin, Professor of Chemistry at Portland State University.

Editor's note

For further information, please contact:

Boulder Diagnostics: Wolfgang Pieken, CEO
6395 Gunpark Drive, Ste W - Boulder, CO 80301
Phone: 720.897.6276 - info@boulderdiagnostics.com
http://www.boulderdiagnostics.com

Portland State University: Joseph Janda, Director of Innovation & Intellectual Property
PO Box 751 - Portland, OR 97207-0751
Phone: 503.725.8454 - iia@pdx.edu
http://www.pdx.edu

About Boulder Diagnostics

Boulder Diagnostics Inc. provides new diagnostic solutions to undeserved or underperforming disease diagnostics areas. It currently markets novel specific antibody reagents for the diagnosis of parasite infections.

About Portland State University (PSU)

Located in Portland, Oregon, PSU has about 30,000 undergraduate and graduate students. PSU's motto is "Let Knowledge Serve the City," and it provides every student with opportunities to work with businesses, schools and organizations on real-world projects. Its downtown campus exhibits PSU's commitment to sustainability through green buildings and business practice. Sustainability is incorporated into much of PSU's curriculum.

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Boulder Diagnostics Inc.; Portland State University
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. CU-Boulder python study may have implications for human heart health
2. Novel CU-Boulder technique shrinks size of nanotechnology circuitry
3. Ultrafast lasers give CU-Boulder researchers a snapshot of electrons in action
4. India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
5. QIAGEN Gains Rights to Genomic Biomarkers for Lung, Brain and Other Cancers to Expand its Pipeline of Companion Diagnostics
6. Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic
7. SuperNova Diagnostics® to Present at Biotech Showcase™ 2012 During JP Morgan Healthcare Conference January 9 - 12
8. S.E.D. Labs to be Acquired by Quest Diagnostics
9. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
10. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
11. Quest Diagnostics CE Marks Simplexa™ Test for Cytomegalovirus for Sale in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... and WASHINGTON , March 28, ... provider, GENEWIZ, will launch single-cell sequencing during the American Association ... E. Washington Convention Center in Washington, D.C. ... to perform differential gene expression of thousands of cells ... Experts on-hand at AACR ...
(Date:3/28/2017)... , March 28, 2017 Dr. ... international life sciences corporation Anpac Bio-Medical Science ... a new, international record, processing and reporting over ... "Cancer Differentiation Analysis" (CDA) liquid biopsy tests. ... Nobel Prize Laureate Summit publications, Anpac Bio,s CDA ...
(Date:3/28/2017)... , March 28, 2017 ... and unpredictable sector due to the scientifically intensive ... include medical, agricultural, environmental, and industrial. In today,s pre-market ... Portola Pharmaceuticals Inc. (NASDAQ: PTLA), OvaScience Inc. (NASDAQ: ... Therapeutix Inc. (NASDAQ: OCUL ). Learn ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... Harvill as Chief Executive Officer with Avomeen Analytical Services. Harvill is a distinguished ... and operations. , Avomeen is a leader in a wide range of ...
Breaking Biology Technology:
(Date:3/2/2017)... Summary This report provides all the ... interests and activities since 2010. ... Read the full report: http://www.reportlinker.com/p03605615-summary/view-report.html ... report provides an in-depth insight into the partnering activity of ... On demand company reports are prepared upon purchase to ensure ...
(Date:3/2/2017)... Australia , March 2, 2017 Australian ... Ltd (ASX: CYP), has signed an agreement with ... from the Monash Biomedicine Discovery Institute and Department of ... to conduct a further preclinical study to support the ... treatment of asthma.  Asthma is a ...
(Date:2/28/2017)... News solutions for biometrics, bag drop and New ADA-compliant ... At PTE ... March, Materna will present its complete end-to-end passenger journey, ... real benefit for passengers. To accelerate the whole passenger handling ... solutions to take passengers through the complete integrated process with ...
Breaking Biology News(10 mins):